Clear-Com unveiled FreeSpeak Cell, a cellular-based wireless intercom system designed to run over LTE and 5G networks and support large-scale, full‑duplex production communications. The system is ...

"Imaging using [⁸⁹Zr]Zr-girentuximab has the potential to change clinical practice in renal cell carcinoma," write the study authors. HealthDay News — ⁸⁹Zr-labeled monoclonal antibody ...

Clear cell RCC is the most common histologic subtype of malignant tumors of the kidney. This histology accounts for 75% of renal masses that are evaluated. 7,8 Clear cell RCC derives from the proximal ...

Adjuvant everolimus does not improve recurrence-free or overall survival in patients with papillary and chromophobe subtypes of non–clear cell renal cell carcinoma (RCC) and is associated with higher ...

For decades, researchers have been seeking a therapy to improve outcomes for patients with clear cell renal cell carcinoma who underwent a nephrectomy. Postsurgical immunotherapy significantly ...

Renal cell carcinoma (RCC) is one of the 10 most commonly diagnosed solid tumors. Most RCCs are histologically defined as clear cell, comprising approximately 75% of diagnoses. However, the remaining ...

Belzutifan, a hypoxia-inducible factor 2α inhibitor, showed clinical activity in clear-cell renal-cell carcinoma in early-phase studies. In a phase 3, multicenter, open-label, active-controlled trial, ...

Learn diagnosis, treatments, side effects and key questions to help guide shared decisions with your oncology team after stage 4 ccRCC diagnosis. Stage 4 clear cell renal cell carcinoma (ccRCC) is the ...